Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FU005
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,777
Award facts
- Contract value 100% obligated
- $32,777.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on November 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Repatha 140 mg/mL SureClick auto-injectors with a ceiling value of $32,777.22 and a firm fixed price structure. The order is non-competitive and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 19, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
Repatha is a PCSK9 inhibitor used for managing high cholesterol in patients at risk for cardiovascular disease, and its inclusion in federal medical procurement reflects the Defense Health Agency's commitment to providing comprehensive pharmaceutical support to service members and beneficiaries. AmerisourceBergen Drug Corp's role as a prime vendor under the DLA Troop Support Medical contract demonstrates its established capacity to meet federal pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications that support military healthcare operations worldwide. The parent IDC enables efficient procurement of critical medical commodities while maintaining competitive pricing and supply chain flexibility for the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FU005?
SPE2DR26FU005 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FU005 worth?
The government has obligated $32,777 on SPE2DR26FU005.
Is contract SPE2DR26FU005 an order under another contract?
Yes. SPE2DR26FU005 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU005 competed?
The extent of competition for SPE2DR26FU005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award